FDA – medicarereport.org

Friday, March 21, 2025

Latest:

FDA Health Care - General HHS Medicaid Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook January 22, 2025January 22, 2025 CMS, Healthcare Costs, Healthcare Finance, HHS, Medicaid, medicare, Medicare Advantage, Medicare Part D

How Does the Department of Health and Human Services (HHS) Impact Health and Health Care?

(By Rakesh Singh for The Kaiser Family Foundation Published: Jan 21, 2025) With President Trump now in office, his cabinet

Artificial Intelligence FDA Medical Technology

Eileen Cook January 8, 2025January 8, 2025 AI-enabled Devices, FDA, Medical Technology

FDA issues draft guidance for AI-enabled devices

(By Alexandra Murphy for Becker’s Hospital Review) The FDA has released draft guidance for developers of AI-enabled medical devices, offering

FDA Part D/Prescription Drugs

Eileen Cook December 24, 2024 FDA, Generic Drugs, GLP-1 drugs, Victoza

FDA approves GLP-1 generic

(By Paige Twenter for Becker’s Hospital Review) On Dec. 23, the FDA approved Hikma Pharmaceuticals’ liraglutide injection, a generic version

FDA Part D/Prescription Drugs

Eileen Cook December 23, 2024December 23, 2024 FDA, sleep apnea, Weight-loss drugs, Zepbound

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea

(By Juliana Kim for NPR) The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive

FDA Health Care Redesign Medicaid Medicare - General Part D/Prescription Drugs

Eileen Cook November 22, 2024November 22, 2024 Canadian Drug Import, Drug Industry, FDA, Lower Drug Costs, Medicaid, medicare

Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval

(By Phil Galewitz for KFF Health News) Nearly a year after the Biden administration gave Florida the green light to

FDA Part D/Prescription Drugs

Eileen Cook November 7, 2024November 7, 2024 FDA, GLP-1 drugs, Mounjaro, Ozempic

FDA adds warning to Ozempic, Mounjaro and other GLP-1 labels

(By Alexandra Murphy for Becker’s Hospital Review) The FDA has updated the labels for all GLP-1 receptor agonists, including popular

FDA Medical Technology Pandemic

Eileen Cook November 5, 2024November 5, 2024 COVID-19 Pandemic, FDA, Healthcare Supply Chain, Medical Supplies Shortages

Why hospitals still can’t get the supplies they need

(By Stefanie Asin for Becker’s Hospital Review) During the COVID-19 pandemic, healthcare supply chain issues were complex and plentiful, creating

FDA Health Care Finance Part D/Prescription Drugs

Eileen Cook September 12, 2024September 12, 2024 Biosimilars drugs, FDA, Healthcare Finance, Humira, Medicare Part D

Optum joins CVS, Cigna in dropping Humira

(By Rylee Wilson for Becker’s Hospital Review) Optum Rx will join the other major pharmacy benefit managers and exclude Humira

FDA Health Care Finance Medicare - General Part D/Prescription Drugs

Eileen Cook September 9, 2024September 9, 2024 FDA, Healthcare Costs, Healthcare Finance, medicare, Medicare Part D, TV Drug Ads

With TV Drug Ads, What You See Is Not Necessarily What You Get

(By Elisabeth Rosenthal for KFF Health News) Triumphant music plays as cancer patients go camping, do some gardening, and watch

Emerging Health Issues FDA Part D/Prescription Drugs

Eileen Cook September 4, 2024September 4, 2024 Drug Shortages, FDA, Medicare Part D

6 drugs now in shortage

(By Paige Twenter for Becker’s Hospital Review) The sole suppliers for a few medications, including a Parkinson’s disease therapy, are

← Previous